New pill takes on Hard-to-Treat cancers in first human trial
Disease control
Recruiting now
This early-phase study tests an experimental oral drug called CID-078 in 220 adults with advanced solid tumors that have stopped responding to standard treatments. The goal is to see if the drug is safe and can shrink tumors. It is a first-in-human trial, so the main focus is on …
Phase: PHASE1 • Sponsor: Circle Pharma • Aim: Disease control
Last updated May 11, 2026 20:49 UTC